Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 54 (TRIM54) is a cytoplasmic E3 ubiquitin ligase belonging to the TRIM family, characterized by a RING-type domain and responsible for regulating protein degradation via the ubiquitin-proteasome pathway. Highly expressed in striated muscle, heart, and testis, TRIM54 modulates skeletal muscle development, myotube formation, and microtubule stability. In cancer cells, TRIM54 acts as an oncogene: in hepatocellular carcinoma, it promotes proliferation and metastasis by degrading Axin1 and upregulating Wnt/β-catenin signaling; in gastric cancer, TRIM54 facilitates tumor progression via K63-linked ubiquitination and degradation of filamin C. TRIM54 expression serves as a prognostic biomarker for several cancers and acute myocardial infarction. While a promising therapeutic target due to its role in multiple pathological processes (muscular, cardiovascular, oncological diseases), direct inhibitors are not currently available and its inhibition may pose risks to muscle function
E3 ubiquitin ligase activity: facilitates polyubiquitination and proteasomal degradation of negative regulators such as Axin1 (leading to Wnt/β-catenin signaling activation). K63-linked ubiquitination and degradation of filamin C (FLNC), affecting cell structure and migration.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 54 (TRIM54).